1. Downregulation of WW domain-containing oxidoreductase leads to tamoxifen-resistance by the inactivation of Hippo signaling
   Juan Li et al, 2019, Experimental Biology and Medicine CrossRef
2. Regulatory Roles of MAPK Phosphatases in Cancer
   Heng Boon Low et al, 2016, Immune Network CrossRef
3. A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen
   Kang Wang et al, 2018, Scientific Reports CrossRef
4. Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
   Jie Liu et al, 2020, Journal of Cellular and Molecular Medicine CrossRef
5. Development of local injectable, bone-targeting nanocarriers of triptolide for treatment of bone-only metastasis
   Wucheng Wen et al, 2022, International Journal of Pharmaceutics CrossRef
6. TUFT1 is expressed in breast cancer and involved in cancer cell proliferation and survival
   Weiguang Liu et al, 2017, Oncotarget CrossRef
7. Paclitaxel Reversed Trastuzumab Resistance Via Regulating JUN in Human Gastric Cancer Cells Identified by FAN Analysis
   Zhe Wang et al, 2018, Future Oncology CrossRef
8. Sanguinarine highly sensitises breast cancer cells to doxorubicin-induced apoptosis
   Manisha du Plessis et al, 2024, South African Journal of Science CrossRef
9. Influence of nNav1.5 on MHC class I expression in breast cancer
   Ahmad Hafiz Murtadha et al, 2021, Journal of Biosciences CrossRef
10. Phosphatases and solid tumors: focus on glioblastoma initiation, progression and recurrences
    Matthias Dedobbeleer et al, 2017, Biochemical Journal CrossRef
11. Mitogen-activated protein kinase phosphatase 1 protects PC12 cells from amyloid beta-induced neurotoxicity
    Xiao-Ping Li et al, 2018, Neural Regeneration Research CrossRef